| International meta-analysis of PTSD genome-wide association studies identifies sex-and ancestry-specific genetic risk loci CM Nievergelt, AX Maihofer, T Klengel, EG Atkinson, CY Chen, KW Choi, ... Nature Communications 10 (1), 1-16, 2019 | 443 | 2019 |
| Treatment of behavioral emergencies MH Allen, GW Currier, DH Hughes, M Reyes-Harde, JP Docherty Postgraduate Medicine 109, 2001 | 309 | 2001 |
| Induction of hippocampal long-term depression requires release of Ca2+ from separate presynaptic and postsynaptic intracellular stores M Reyes, PK Stanton Journal of Neuroscience 16 (19), 5951-5960, 1996 | 226 | 1996 |
| Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double‐blind, placebo‐controlled study M Haas, MP DelBello, G Pandina, S Kushner, I Van Hove, I Augustyns, ... Bipolar disorders 11 (7), 687-700, 2009 | 206 | 2009 |
| A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders M Reyes, J Buitelaar, P Toren, I Augustyns, M Eerdekens American Journal of Psychiatry 163 (3), 402-410, 2006 | 189 | 2006 |
| A 6-week, randomized, double-blind, placebo-controlled study of the efficacy and safety of risperidone in adolescents with schizophrenia M Haas, AS Unis, J Armenteros, MD Copenhaver, JA Quiroz, SF Kushner Journal of child and adolescent psychopharmacology 19 (6), 611-621, 2009 | 159 | 2009 |
| tranSMART: an open source and community-driven informatics and data sharing platform for clinical and translational research BD Athey, M Braxenthaler, M Haas, Y Guo AMIA Summits on Translational Science Proceedings 2013, 6, 2013 | 148 | 2013 |
| Management of psychiatric disorders in children and adolescents with atypical antipsychotics PS Jensen, J Buitelaar, GJ Pandina, C Binder, M Haas European child & adolescent psychiatry 16 (2), 104-120, 2007 | 144 | 2007 |
| Efficacy, safety and tolerability of two risperidone dosing regimens in adolescent schizophrenia: double-blind study M Haas, M Eerdekens, S Kushner, J Singer, I Augustyns, J Quiroz, ... The British Journal of Psychiatry 194 (2), 158-164, 2009 | 123 | 2009 |
| Induction of Hippocampal LTD Requires Nitric-Oxide-Stimulated PKG Activity and Ca2+ Release From Cyclic ADP-Ribose-Sensitive Stores M Reyes-Harde, BVL Potter, A Galione, PK Stanton Journal of neurophysiology 82 (3), 1569-1576, 1999 | 120 | 1999 |
| Evidence of a role for cyclic ADP-ribose in long-term synaptic depression in hippocampus M Reyes-Harde, R Empson, BVL Potter, A Galione, PK Stanton Proceedings of the National Academy of Sciences 96 (7), 4061-4066, 1999 | 117 | 1999 |
| Long-term use of risperidone in children with disruptive behavior disorders and subaverage intelligence: efficacy, safety, and tolerability M Reyes, J Croonenberghs, I Augustyns, M Eerdekens Journal of Child & Adolescent Psychopharmacology 16 (3), 260-272, 2006 | 80 | 2006 |
| Big data to smart data in Alzheimer's disease: The brain health modeling initiative to foster actionable knowledge H Geerts, PA Dacks, V Devanarayan, M Haas, ZS Khachaturian, ... Alzheimer's & Dementia 12 (9), 1014-1021, 2016 | 77 | 2016 |
| 2014 Report on the milestones for the US national plan to address Alzheimer's disease Alzheimer's Association National Plan Milestone Workgroup, KN Fargo, ... Alzheimer's & Dementia 10, S430-S452, 2014 | 66 | 2014 |
| Nitric‐oxide‐guanylyl‐cyclase‐dependent and‐independent components of multiple forms of long‐term synaptic depression AT Gage, M Reyes, PK Stanton Hippocampus 7 (3), 286-295, 1997 | 66 | 1997 |
| Genomic influences on self-reported childhood maltreatment S Dalvie, AX Maihofer, JRI Coleman, B Bradley, G Breen, LA Brick, ... Translational psychiatry 10 (1), 1-12, 2020 | 61 | 2020 |
| Long-term safety and efficacy of risperidone in children with disruptive behaviour disorders M Reyes, R Olah, K Csaba, I Augustyns, M Eerdekens European child & adolescent psychiatry 15 (2), 97-104, 2006 | 56 | 2006 |
| Chemically induced, activity-independent LTD elicited by simultaneous activation of PKG and inhibition of PKA L Santschi, M Reyes-Harde, PK Stanton Journal of neurophysiology 82 (3), 1577-1589, 1999 | 56 | 1999 |
| Alzheimer's disease research and development: a call for a new research roadmap HH Feldman, M Haas, S Gandy, DD Schoepp, AJ Cross, R Mayeux, ... Annals of the New York Academy of Sciences 1313 (1), 1-16, 2014 | 52 | 2014 |
| Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures E Faught, GL Holmes, WE Rosenfeld, G Novak, W Neto, A Greenspan, ... Neurology 71 (20), 1586-1593, 2008 | 49 | 2008 |
